Craig-Hallum initiated coverage of Veracyte (VCYT) with a Buy rating and $45 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VCYT:
- Veracyte’s Strong Market Position and Growth Potential Drive Buy Rating
- Veracyte Inc. Reports Strong 2024 Earnings Amid Challenges
- Veracyte’s Strong Q4 2024 Performance and Strategic Moves Justify Buy Rating
- Veracyte Inc. Reports Strong 2024 Financial Performance
- Veracyte sees FY25 testing revenue $470M-$480M
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue